250 related articles for article (PubMed ID: 35468848)
1. Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease.
Ding Q; Kesavan K; Lee KM; Wimberger E; Robertson T; Gill M; Power D; Chang J; Fard AT; Mar JC; Henderson RD; Heggie S; McCombe PA; Jeffree RL; Colditz MJ; Hilliard MA; Ng DCH; Steyn FJ; Phillips WD; Wolvetang EJ; Ngo ST; Noakes PG
Acta Neuropathol Commun; 2022 Apr; 10(1):61. PubMed ID: 35468848
[TBL] [Abstract][Full Text] [Related]
2. Structural mechanisms of the agrin-LRP4-MuSK signaling pathway in neuromuscular junction differentiation.
Zong Y; Jin R
Cell Mol Life Sci; 2013 Sep; 70(17):3077-88. PubMed ID: 23178848
[TBL] [Abstract][Full Text] [Related]
3. Agrin/Lrp4 signal constrains MuSK-dependent neuromuscular synapse development in appendicular muscle.
Walker LJ; Roque RA; Navarro MF; Granato M
Development; 2021 Nov; 148(21):. PubMed ID: 34714331
[TBL] [Abstract][Full Text] [Related]
4. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
[TBL] [Abstract][Full Text] [Related]
5. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
[TBL] [Abstract][Full Text] [Related]
6. Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK).
Zhang W; Coldefy AS; Hubbard SR; Burden SJ
J Biol Chem; 2011 Nov; 286(47):40624-30. PubMed ID: 21969364
[TBL] [Abstract][Full Text] [Related]
7. The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction.
Uyen Dao TM; Barbeau S; Messéant J; Della-Gaspera B; Bouceba T; Semprez F; Legay C; Dobbertin A
J Biol Chem; 2023 Aug; 299(8):104962. PubMed ID: 37356721
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the assembly of the agrin/LRP4/MuSK signaling complex.
Xie T; Xu G; Liu Y; Quade B; Lin W; Bai XC
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2300453120. PubMed ID: 37252960
[TBL] [Abstract][Full Text] [Related]
9. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
[TBL] [Abstract][Full Text] [Related]
10. Structure and activation of MuSK, a receptor tyrosine kinase central to neuromuscular junction formation.
Hubbard SR; Gnanasambandan K
Biochim Biophys Acta; 2013 Oct; 1834(10):2166-9. PubMed ID: 23467009
[TBL] [Abstract][Full Text] [Related]
11. MuSk function during health and disease.
Herbst R
Neurosci Lett; 2020 Jan; 716():134676. PubMed ID: 31811897
[TBL] [Abstract][Full Text] [Related]
12. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
[TBL] [Abstract][Full Text] [Related]
13. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders.
Ohno K; Ohkawara B; Ito M
Expert Opin Ther Targets; 2017 Oct; 21(10):949-958. PubMed ID: 28825343
[TBL] [Abstract][Full Text] [Related]
14. Lrp4 is a receptor for Agrin and forms a complex with MuSK.
Kim N; Stiegler AL; Cameron TO; Hallock PT; Gomez AM; Huang JH; Hubbard SR; Dustin ML; Burden SJ
Cell; 2008 Oct; 135(2):334-42. PubMed ID: 18848351
[TBL] [Abstract][Full Text] [Related]
15. LRP4 serves as a coreceptor of agrin.
Zhang B; Luo S; Wang Q; Suzuki T; Xiong WC; Mei L
Neuron; 2008 Oct; 60(2):285-97. PubMed ID: 18957220
[TBL] [Abstract][Full Text] [Related]
16. APP interacts with LRP4 and agrin to coordinate the development of the neuromuscular junction in mice.
Choi HY; Liu Y; Tennert C; Sugiura Y; Karakatsani A; Kröger S; Johnson EB; Hammer RE; Lin W; Herz J
Elife; 2013 Aug; 2():e00220. PubMed ID: 23986861
[TBL] [Abstract][Full Text] [Related]
17. Multiple MuSK signaling pathways and the aging neuromuscular junction.
Fish LA; Fallon JR
Neurosci Lett; 2020 Jul; 731():135014. PubMed ID: 32353380
[TBL] [Abstract][Full Text] [Related]
18. Sarcoglycan Alpha Mitigates Neuromuscular Junction Decline in Aged Mice by Stabilizing LRP4.
Zhao K; Shen C; Li L; Wu H; Xing G; Dong Z; Jing H; Chen W; Zhang H; Tan Z; Pan J; Xiong L; Wang H; Cui W; Sun XD; Li S; Huang X; Xiong WC; Mei L
J Neurosci; 2018 Oct; 38(41):8860-8873. PubMed ID: 30171091
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanisms underlying the formation and maintenance of neuromuscular junctions and a possible therapeutic approach.].
Eguchi T; Tezuka T; Miyoshi S; Yamanashi Y
Clin Calcium; 2017; 27(3):413-419. PubMed ID: 28232656
[TBL] [Abstract][Full Text] [Related]
20. Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice.
Lin S; Maj M; Bezakova G; Magyar JP; Brenner HR; Ruegg MA
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11406-11. PubMed ID: 18685098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
